Bo Peng is currently the CMC Regulatory Affairs Manager at AstraZeneca, a position held since 2024. They previously completed a summer internship at SDR Consulting Co., Ltd in 2010 and conducted a Master Thesis Project at AstraZeneca in 2015, focusing on perfusion de-cellularization of rodent hearts. Bo has also held various roles at AstraZeneca as a Bioscience Scientist, contributing to research on drug development and molecular biology. They earned a Bachelor of Engineering in Bioengineering from Northwest A & F University and a Master of Science in Biotechnology from Chalmers University of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices